ProQR Therapeutics N.V. buy Citigroup Inc.
Start price
10.03.25
/
50%
€1.87
Target price
10.03.26
€3.68
Performance (%)
-28.20%
Price
07:37
?
Summary
This prediction is currently active. The price of ProQR Therapeutics N.V. has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.20%. This prediction currently runs until 10.03.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | -1.868% | -1.868% |
| iShares Core DAX® | 0.170% | 2.184% |
| iShares Nasdaq 100 | 0.515% | 0.370% |
| iShares Nikkei 225® | 1.614% | 6.357% |
| iShares S&P 500 | -0.719% | -0.275% |
Comments by Citigroup_Inc_ for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $4.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.78
19.04.24
19.04.24
€1.88
19.04.25
19.04.25
-36.85%
20.04.25
20.04.25
